Nidan Laboratories and Healthcare (NSE:NIDAN) Market Cap : ₹455.9 Mil (As of Jun. 20, 2024)

Nidan Laboratories and Healthcare Market Cap Chart

Competitive Comparison of Nidan Laboratories and Healthcare's Market Cap

For the Diagnostics & Research subindustry, Nidan Laboratories and Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nidan Laboratories and Healthcare's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nidan Laboratories and Healthcare's Market Cap distribution charts can be found below:

* The bar in red indicates where Nidan Laboratories and Healthcare's Market Cap falls into.

Nidan Laboratories and Healthcare Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nidan Laboratories and Healthcare's Market Cap for the fiscal year that ended in Mar. 2021 is calculated as

Nidan Laboratories and Healthcare's Market Cap for the quarter that ended in Mar. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare  (NSE:NIDAN) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Nidan Laboratories and Healthcare Market Cap Related Terms

Thank you for viewing the detailed overview of Nidan Laboratories and Healthcare's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Nidan Laboratories and Healthcare (NSE:NIDAN) Business Description